In male mice, the Hetero control group showed only a slight trend toward reduced movement compared to Wild controls, and KDS2010 treatment had no significant effect (Figure 3B ).
← all excerpts
Oral KDS2010, a Monoamine Oxidase-B (MAO-B) Inhibitor, Slows the Deterioration of Motor Coordination in Genetic SCA1 Models by Inhibiting Astrocytic MAO-B-Mediated Inflammation.
3
—
—
The sentences
KDS2010 treatment restored the thickness to levels comparable to Wild controls in both sexes, although the effect did not reach statistical significance (Figure 4D,G ).
The KDS2010 administration group did not improve the hindlimb clasp test in males but showed a trend (Figure 1G,H ).